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Neuraxial anesthesia is a term that denotes all forms of central blocks, involving the spinal, epidural, and caudal spaces. Epidural
anesthesiaisaversatiletechniquewidelyusedinanestheticpractice.Itspotentialtodecreasepostoperativemorbidityandmortality
has been demonstrated by numerous studies. To maximize its perioperative beneﬁts while minimizing potential adverse outcomes,
the knowledge of factors aﬀecting successful block placement is essential. This paper will provide an overview of the pertinent
anatomical, pharmacological, immunological, and technical aspects of epidural anesthesia in both adult and pediatric populations
and will discuss the recent advances, the related rare but potentially devastating complications, and the current recommendations
for the use of anticoagulants in the setting of neuraxial block placement.
1.Introduction
Neuraxial anesthesia is the term for central blocks involving
the spinal, epidural, and caudal spaces. While it is now
an invaluable adjunct and even occasionally an alternative
to general anesthesia, its use is not a new phenomenon.
Physicians such as Corning published studies documenting
success with neuraxial blocks as early as 1885 [1]. Even more
ambitious physician-scientists such as Bier became knowl-
edgeable about spinal anesthesia, in particular, through self-
investigation [2]. It unfortunately was also through this type
of dedication that he became all too familiar with postdural
puncture headaches. Despite its early use, though, much
of the gains we have with neuraxial blocks did not occur
until the early 1900’s. Limitations in this particular area of
anesthesia were limited to lack of drug diversity and a lack of
adequate equipment. Prior to 1904, the only drug available
for neuraxial use was cocaine, and development of epidural
t e c h n o l o g yw a ss t i l law a y so ﬀ. With a larger drug base and
equipment advancements came an expansion of the role of
neuraxial anesthesia in anesthesia practice.
Excluding the obvious fact that surgical conditions
primarily dictate the type of anesthesia performed, most
operations below the neck canbe performedunder neuraxial
anesthesia. Various studies have shown a decrease in post-
operative morbidity and even mortality when used either
with general anesthesia or alone. Neuraxial blocks have even
been shown to reduce the incidence of venous thrombosis
and pulmonary embolism while also minimizing transfu-
sion requirements and respiratory compromise following
thoracic and upper abdominal surgery. A decreased stress
responsehasalsobeennotedwhichmayhavepositivecardiac
b e n e ﬁ t ss u c ha sr e d u c e dp e r i o p e r a t i v ea n dp o s t o p e r a t i v e
ischemia. Despite these proposed advantages of neuraxial
blocks, adverse reactions and complications can occur. These
can range from self-limited back soreness to permanent
neurologic deﬁcits and even death. Because an expansive
review of neuraxial blocks is beyond the scope of this review,
we have chosen to focus our discussion to epidural and
caudal anesthesia. In doing so, we will review pertinent
epidural knowledge, and present cutting edge advances
speciﬁc to epidural and caudal anesthesia.
2. Anatomy for EpiduralPlacement
The anatomy for the placement of an epidural goes beyond
the epidural space itself. It is for this reason that this section
will not only cover anatomy of this space, but also important
surrounding anatomy.
The epidural space extends from the base of the skull
to the sacral hiatus. Its lateral boundaries are the vertebral
pedicles, while the anterior and posterior boundaries are2 Anesthesiology Research and Practice
the dura mater and ligamentum ﬂavum, respectively. The
contents of the space include fat, lymphatics, and veins with
nerverootsthatcrossit.Determinantsofepiduralfatinclude
age and body habitus with obese patients having the greatest
amountofepiduralfat[2].Theamountofepiduralfatwithin
the space is just one of the factors that determine volume
necessary for adequate anesthesia or analgesia.
Veins within the epidural space form a plexus called
Batson’s venous plexus. These veins connect with the iliac
andazygosveinsandaresigniﬁcantbecauseofalackofvalves
commonly found in veins. It is the lack of these valves in
conjunction with a compressed inferior vena cava from a
gravid uterus, which results in the venous engorgement of
epidural veins found in parturients.
Traditional thought on epidural anatomy was that it is
one continuous space. A more recent thought is the concept
of it being a potential space with septations or crevices
formed by layering of epidural contents (fat). The anatomic
layering and texture of epidural contents create inconsistent
paths that ultimately make ﬂow through it less uniform [3].
The idea of these septations or crevices forming variable
paths for the ﬂow of a solution is the rationale given for
unilateral or partial epidural blockade [4].
Vertebral spinous processes help deﬁne the midline. In
the cervical and lumbar areas they are horizontal, while
in the thoracic vertebrae (speciﬁcally T4 through T9) they
are caudally angulated. The space between these caudally
angulated spinous processes are often diﬃcult to access
leading some to favor a paramedian approach to thoracic
epidural placement as opposed to the traditional midline
approach. While the surgical site dictates the level of the
epidural placement, the safest location is one whereby
inadvertent spinal cord damage can be avoided. In adults,
the spinal cord typically ends at the lower border of the L1
vertebra while in children it is at the level of the lower border
of L3. By the age of 8 years, one can safely target the same
lumbar levels for safe epidural placement as in the adult,
while under the age of 7 years, a caudal approach to the
epidural space is safest. One generally accepted landmark for
assessing lumbar level for epidural placement is the superior
aspect of the iliac crest. A horizontal line drawn between the
superior borders of either iliac crest corresponds to the L4
vertebral body or the L4-5 interspace. For thoracic epidural
placement, the inferior border of the scapula is the usual site
of the T7 vertebral body/spinous process, and is typically
used to approximate thoracic level of epidural placement
for thoracic or intraabdominal surgical procedures. The
approximate distance from the skin to the epidural space in
80% of individuals is 4–6cm with the caveat that thin and
obese patients may vary outside of this range [5].
3. Choices for Epidural Infusions
Local anesthetics are the mainstay of therapy for obtaining
analgesia or anesthesia with an epidural. Understanding the
pharmacology of local anesthetics is therefore paramount.
Speciﬁcally, factors such as surgical location and duration,
desire to have a sensory and/or motor block, or the expected
potency and duration of a speciﬁc local anesthetic agent
should be considered prior to placing an epidural block.
The choice of which local anesthetic agent to use can be
categorized based on desired length of action. Regardless
of the class of local anesthetic, these drugs can be divided
into ones that are short, intermediate, or long acting. The
shortest-acting local anesthetic agent is chloroprocaine. Its
short length provides ample anesthesia for short surgical
procedures, and its quick elimination obviates the need for
prolonged recovery room discharges.
Lidocaine has traditionally been the agent of choice
for slightly longer surgical procedures that require an
intermediate-acting local anesthetic. In place of lidocaine,
some centers have also adopted the use of mepivacaine for its
longerlengthofactionwithasimilaronsetproﬁle.Theinter-
mediate length of action of either agent can be prolonged by
the addition of epinephrine. Of note is the potential for an
increased incidence of hypotension due to venous pooling
from the beta eﬀects of epinephrine containing solutions.
This phenomenon seems to be especially true of patients
receiving lumbar epidural analgesia.
Longer-acting local anesthetics used for epidural block-
ade typically consist of either bupivacaine or ropivacaine in
varying concentrations. Greater concentrations of either will
produce a greater motor block in addition to the sensory
block that is typically desired. Ropivacaine, an analog of
mepivacaine, has a lesser intense and shorter duration of
motor block in addition to a lower toxicity proﬁle than
an equipotent dose of bupivacaine [6]. The cardiac toxicity
proﬁle of bupivacaine is the highest among all the choices of
local anesthetics. It is due to a high degree of protein binding
and a greater blocking eﬀect on cardiac sodium channels.
Multiple attempts have been made to ﬁnd various addi-
tives to improve the onset and duration of an epidural block.
Alkalinization with sodium bicarbonate has proven eﬀective
inadoseof1mEq/10mLlocalanestheticforchloroprocaine,
lidocaine, or mepivacaine. A lower concentration of sodium
bicarbonate (0.1mEq/10mL of local anesthetic) is necessary
for bupivacaine and ropivacaine due to the potential of
precipitation with higher concentrations. The addition of
epinephrine to a local anesthetic increases the duration of
action by decreasing the vascular absorption. While this
phenomenon has been shown to be true with the short-
and intermediate-acting local anesthetic agents, it appears
to be less eﬀective with longer-acting agents. With the
low doses typically used in the epidural space, the overall
cardiovascular response seems to be vasodilation (causing a
decreaseinmeanarterialpressure),inadditiontoanincrease
in heart rate and contractility. These eﬀects ultimately result
in maintenance of cardiac output. Phenylephrine has also
beenusedtoprolongtheeﬀectsofneuraxiallocalanesthetics.
In contrast to the use of epinephrine in the epidural
space, it causes an increase in peripheral vascular resistance
without the added beneﬁts of an increase in chronotropy
or contractility. The resulting drop in cardiac output is the
reason most anesthesiologists avoid phenylephrine in the
epidural space.
Opioids remain the analgesic adjuvant of choice for aug-
menting the eﬀects of local anesthetics in the epidural space.
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shown to signiﬁcantly reduce volatile agent requirements by
morethantwofoldinsomeinstances[7].Despitethebeneﬁts
of neuraxial opioids, side eﬀects do occur. Some of the more
common side eﬀects are pruritus (speciﬁcally in the mid-
facial area), nausea, and urinary retention. Hypotension can
alsooccurwhichisattributedtothereductionofsympathetic
outﬂow via opioid receptors in the sympathetic ganglia.
Another class of analgesic adjuvants includes alpha-
adrenergic agonists. Clonidine is the main drug used in
this class due to its production as a preservative-free prepa-
ration. The eﬀects of epidurally administered clonidine
are seen as early as 20 minutes after injection, with peak
eﬀects occurring in 1 hour. The analgesic potency has been
described as being comparable to epidurally administered
morphine [8]. Adding clonidine to opioids in the epidural
space has an additive eﬀect, which results in a lower dose
of narcotic necessary for optimal pain control. This as a
consequence diminishes the incidence of respiratory depres-
sion that potentially occurs with neuraxial opioids. Cloni-
dine is lipophilic, and as a result is quickly redistributed
systemically despite neuraxial injection. It therefore has both
central and peripheral eﬀects. At lower doses, the central
eﬀects cause sympatholysis leading to hypotension, while
the peripheral eﬀects at higher doses cause vasoconstriction.
Clonidine administered in the low thoracic or lumbar region
typically produces blood pressure eﬀects similar to that
seen with intravenous administration [9]. When given in
the mid or upper thoracic regions, epidurally administered
clonidine causes an even greater decrease in blood pressure
[10]. This more substantial drop in blood pressure is
attributed to blocking thoracic dermatomes that contribute
to sympathetic ﬁbers innervating the heart. In addition
to the hypotensive potential of clonidine, bradycardia, and
nausea with or without vomiting are also potential side
eﬀects. The cause of bradycardia is twofold. Clonidine has
vagomimeticeﬀectsinadditiontoinhibitingnorepinephrine
release. Additional side eﬀects such as sedation and dry
mouth are possible, but seem to be dose related. Even
more esoteric compounds such as neostigmine, ketamine,
ketorolac, midazolam, and dexamethasone are being studied
with hopes to develop additional tools to supplement or
even replace the neuraxial analgesia and anesthesia of local
anesthetics. While this discussion focuses on epidural use
of these agents, their clinical use may have far greater
application. Current studies are not only investigating these
agentsintheacutepainsetting,butarealsoforuseinvarious
chronic pain disorders.
4.The Effect of Anesthetic Techniqueon
Immune Function
Surgery is associated with a wide range of metabolic, end-
ocrine, hematological, and inﬂammatory/immunological
responses, known collectively as surgical stress response.
Surgical stress response has been identiﬁed as a major
factor accounting for perioperative immune suppression
[11] .T h ee x t e n tt ow h i c ht h i sa d a p t i v er e s p o n s ec a nb e
modiﬁed appears to be dependent on the anesthetic and
analgesic technique used, and with regards to postoperative
outcomes, has been extensively studied [12, 13]. There
is evidence that regional anesthesia, particularly epidural
blockade, attenuates or inhibits surgical stress by blocking
aﬀerent neural stimuli from reaching the central nervous
system, as well as by blocking the eﬀerent activation of the
sympathetic nervous system [14, 15]. The nervous system
accounts for the main common pathway mediating the
surgical stress response [16]. Immune response is subject
to neuroendocrine regulation and elicits neuroendocrine
changes [17], augmenting or blunting the neuroendocrine
response.Itthereforeaﬀectspostoperativeimmunefunction,
and ultimately long-term outcomes [18, 19].
5. Perioperative Immunosuppression and
the Impact ofAnesthetic Technique on
Postoperative Outcomes
Impaired perioperative immunity is related to the neuroen-
docrine stress response. Evidence suggests that the factors
that are associated with immunosuppression during surgery
are surgical stress response, general anesthesia, and opioid
analgesia.
Surgical trauma in itself induces the release of cat-
echolamines, adrenocorticotropic hormone, and cortisol,
depressescell-mediatedimmuneresponsesincluding natural
killer cell and cytotoxic T-cell function [13, 19–21], and
promotes tumor vascularization [22, 23]. Additionally, risk
factors, such as pain [24], blood transfusion [25], hypother-
mia [26], and hyperglycemia [27], further impair immunity.
Pain activates the HPA axis, and may induce accelerated
lymphocyteapoptosis[28].Hypothermiaimpairsneutrophil
oxidative killing by causing thermoregulatory vasoconstric-
tion and thus decreasing oxygen supply [29]. Perioperative
hyperglycemia impairs phagocytic activity and oxidative
burst, as there is less NADPH available due to the activation
of the NADPH consuming polyol pathway [30–32]. Earlier
studies suggested that cell-mediated immune function [33,
34] is reduced by allogenic blood transfusion. Transfusion
has more recently been suggested to facilitate host Th2c e l l s
to produce immunosuppressive IL-4 and IL-10; however, the
exact mechanism of causality is yet unclear [25].
General anesthesia is also considered to be immunosup-
pressive, either by directly aﬀecting immune mechanisms,
or by activating the hypothalamic-pituitary-adrenal (HPA)
axis and the sympathetic nervous system [12, 29]. Volatile
anesthetics,bymechanismsthatareonlypartiallyelucidated,
impair NK cell, T cell, dendritic cell, neutrophil, and
macrophage functions. Furthermore, opioid analgesics were
foundtoinhibitbothcellularandhumoralimmunefunction
in humans [35, 36]. Melamed and colleagues showed that
ketamine, thiopental, and halothane, but not propofol, had
inhibitoryeﬀectsonNKcellactivityandincreasedmetastatic
burden in rats [37].
Opioids suppress the innate and adaptive immune
responses [38, 39]. While neural and neuroendocrine
responses are also involved [40], the presence of opioid-
related receptors on the surface of immune cells increases
thelikelihoodofadirectimmune-modulatingeﬀect[41].De4 Anesthesiology Research and Practice
Waal and colleagues found diﬀerent opioids to have diﬀering
immunosuppressive eﬀects [42]. Synthetic opioids, however,
do not appear to attenuate immune response [43, 44].
These immunosuppressive factors occur simultaneously
during surgery and in the immediate postoperative period.
The perioperative period is therefore a decisive period
during which interventions that promote host defense may
especially beneﬁt the patient [11]. This may be of particular
interest in patients undergoing tumor resection. While
surgery is essential to reduce tumor burden, and among
various treatment options, it is considered to be the most
eﬀective treatment for solid tumors; a rapid spread and
growth of malignant tissue is often observed after tumor
resection [45]. Cancer surgery, even with the best technique,
is usually associated with dissemination of malignant cells
through the lymphatics and the systemic circulation, and, at
the time of surgery, many patients have already established
micrometastases [46]. The clinical manifestation of this
minimal residual disease is a function of both the host
immune competence (particularly NK cell function) and the
tumor’s proliferative and angiogenic abilities [22, 23, 45, 47].
Regional anesthesia reduces the amount of intraoperative
general anesthetics required, has opioid sparing eﬀects, and
markedly attenuates the neuroendocrine stress response to
surgery as well as preserving NK cell function and Th1c e l l
activitybetterthangeneralanesthesia[48].Itishypothesized
that regional anesthesia and analgesia help preserve control
of tumor progression. Modiﬁcation to anesthetic manage-
ment might thus reduce the risk of recurrence [18].
6.ImagingTechniquesduring
EpiduralCatheterization
Identifying the epidural space and correct needle positioning
is often challenging for the novice anesthesiologist. Epidural
catheter placement is thought to be among the most diﬃcult
techniques to acquire [49], with a success rate of as low as
60% at the ﬁrst attempt [50], and an overall success rate
of nearly 90% [51]. Factors contributing to the success or
failure of catheter placement can be surgery related, as the
typeofsurgerydeterminesthespeciﬁcregionofthevertebral
column for block placement [52]; patient dependent, such as
body habitus, presence or absence of identiﬁable anatomical
landmarks, or spinal anatomy; or operator dependent, such
as the degree of personal experience, patient positioning,
needle size, or the use of conventional “blind” versus
imaging-guided techniques [53]. Previous reports suggest
that the conventional “loss of resistance” technique used in
the thoracic and lumbar region may have a false-positive
success rate of as high as 30%, and, although generally
considered reliable for epidural anesthesia, when used as
a sole tool, this clinical sign may not oﬀer the same
potential to accurately identify the epidural space, as when
complemented with an imaging tool [54, 55]. Visualization
of the interlaminar space, accurate estimation of the depth to
the epidural space, and optimal needle insertion angle are
known to facilitate epidural block placement [50, 56, 57].
With the rapidly evolving imaging technology, there has
been an increasing interest in the use of various imaging
tools, to improve success rates of neuraxial blocks. Several
studies have shown the usefulness of both ultrasound guided
and ﬂuoroscopically guided catheter insertion techniques
[49, 58, 59].
6.1. Ultrasound Guided Epidural Catheter Placement. Ultra-
sound is a radiation-free imaging tool that is now widely
used in clinical practice. The ﬁrst successful sonographic
measurement of the epidural space dates back to the
1980s, when Cork and colleagues [60], and Currie [61]
were able to localize and estimate the distance from the
skin to the epidural space. More recently, Bonazzi and de
Gracia identiﬁed the ligamentum ﬂavum in the lumbar
vertebralregion[62].Technicalimprovementinsonographic
visualization,suchastheabilitytodigitallydepictanatomical
structures at high resolution, has much increased the clinical
feasibility of ultrasound in epidural catheter insertion and
visualization [57, 58]. The increasing popularity of this
technique over the past three decades has been attributed
to a more accurate estimation of epidural space depth, a
more optimal determination of the needle insertion point,
and insertion angle particularly in cases of diﬃcult anatomy
(such as obesity, especially during obstetric anesthesia, or
scoliosis), or the presence of implanted hardware [63], and
reduced failure rate [56]. While the use of ultrasound oﬀers
a greater likelihood of successful catheter placement in the
obese patient, morbid obesity may pose technical diﬃculties
tothevisualizationofthevertebralanatomyandtheepidural
space.
Besides the obvious beneﬁts of this radiation-free tech-
nique compared to the conventional “blind” method, there
are disadvantages of ultrasound use in the setting of
epidural block placement. Technically, it can be diﬃcult to
simultaneously stabilize and advance the Tuohy needle, and
maintain the acoustic window, holding the ultrasound probe
in the optimal position. Also, it can be diﬃcult to maintain
continuous visualization of the Tuohy needle tip during
advancement. The use of ultrasound in adults is helpful
for anatomical identiﬁcation, but there is limited published
evidence available for the same degree of usefulness of real
time needle insertion, compared to the pediatric population.
A recent study by Belavy and colleagues, evaluating the
feasibility of real-time 4D ultrasound for epidural catheter
placement in cadavers, found that 4D ultrasound potentially
improves operator orientation of the vertebral column at
the cost of needle visibility and resolution [64–67]. Slight
discrepancy between the sonographically and clinically mea-
sured epidural space depth should be anticipated, likely due
to factors such as tissue deformation during needle passage,
deviationfromthemidline,anddeviationfromthe90degree
insertion angle that has been found to most precisely corre-
late with the sonographically measured skin-epidural space
distance. When compared to the ﬂuoroscopic visualization,
ultrasound guidance does not oﬀer the advantage of placing
the epidural catheter exactly at the desired vertebral level;
also, the depth of the inserted needle may not always be
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6.2. Fluoroscopically Guided Epidural Catheter Placement.
The usefulness of ﬂuoroscopic guidance in epidural block
placement in various regions of the vertebral column has
been established [49, 55, 61]. Previous studies have shown
that more than 50% of lumbar epidurals, in the absence
of appropriate imaging tools, were actually performed at a
level other than the one predicted [68]. A study by Renfrew
and colleagues found that caudal blocks without the use of
ﬂuoroscopy resulted in a 52% incidence of erroneous needle
placement[69],likelyduetothesubfascialcompartmentthat
provides low resistance to injection. Fluoroscopic guidance
oﬀers the advantages of precise needle angulation and
localization of thecatheteratthetargeted vertebrallevel even
in the presence of diﬃcult or unreliable surface anatomy, as
well as accurate identiﬁcation of the epidural space, or the
assessment of injectate dispersal, with the use of contrast dye
to conﬁrm the epidural placement. These factors may also
obviate complications [59]. Fluoroscopy therefore improves
the success rate of epidural block and provides a reliable
delivery of therapeutic substances into the epidural space;
however, both the patient and the operator are exposed to
radiation. Furthermore, this method may only be safe in
patients without contraindication to the use of contrast dye
or radiation itself.
While the use of imaging tools for epidural catheter
placement is gaining increasing popularity for their potential
to increase success rate and reduce complications, the
potential risks and beneﬁts of these methods should be
thoroughly assessed, and the choice of imaging technique
should be determined on an individual basis. It should
be remembered that the use of ultrasound guidance does
not eliminate the need for using the conventional “loss of
resistance” technique, and it is as important as when using
the blind insertion technique.
7. Considerations in the PediatricPopulation
With the development of advanced skills with ultrasound,
guided techniques has attracted an increased interest in its
use for neuraxial blocks. The beneﬁts of identifying anatomy
and directly visualizing needles and catheters, as found with
peripheral blocks, can be of great value for improved success
and conﬁrmation of neuraxial blocks. Because of the large
variation of each patient’s body habitus due to age, it can
be diﬃcult to predict the puncture depth to reach either the
epidural or intrathecal spaces [70].
In pediatric population, checking the anatomy with the
ultrasound before and during performing the procedure
gains and assures a lot of success. Visualization is clearer
than in the adult population due to less ossiﬁcation of
the vertebral column and easiness to predict the epidural
and/or the intrathecal spaces. Loss-of-resistance technique
to identify the epidural space can be very challenging in
neonates due to presence of less ﬁbrous tissue limiting the
tactile feedback [71].
Visibility of the spread of ﬂuid is a promising technique
during injection through the needle and catheter, which
could conﬁrm the position. Using an epidural electrical
stimulation test is another method but the clinical value of
electrical stimulation in caudal needle placement has not
been extensively studied [72].
7.1. Caudal Needle and Catheter Placement under Ultrasound.
Caudal anesthesia is one of the most popular regional
blocks in the pediatric population to provide perioperative
analgesia. Placement of a single shot caudal block or a
lumbar/thoracic epidural catheter achieved through the
caudal epidural space is an advanced skill. This technique
becomes even more complex when considering variation
in patient age, weight, and varying levels of bone ossiﬁ-
cation. Ultrasound guidance for this procedure is helpful
in identifying the underlying anatomic structures. The
ones most commonly of interest include the sacral hiatus,
sacral cornua, coccyx, and sacrococcygeal ligament. While
probe orientation can be done using either a transverse or
longitudinal view of the midline, it is typically best to orient
and assess landmarks prior to performing the procedure
(Figures 1, 2, 3, 4,a n d5).
When introducing a catheter into the caudal space to
reach the lumbar or thoracic spine, a technique similar
to the above is used for cannula placement. The catheter
can then be directly visualized during advancement with
the ultrasound at each level of the spine above the sacrum
(Figures 2(a), 2(b),a n d3).
As is the case during the assessment, either the longitudi-
nal or transverse axes can be used to visualize the underlying
structures and catheter position.
Conﬁrmation of catheter placement can be performed
through visualization of local anesthetic spread as well
as through direct visualization of the catheter within the
epidural space. Catheter tip visibility may be improved with
the injection of a bubble-based ﬂuid or local anesthetic
spreadandaswooshtest(usingastethoscopetolistentoﬂuid
movement).
7.2. Tunneling of Caudal Epidural Catheter. Bacterial col-
onization is regarded as a causative factor for infectious
complications of caudal catheters in children [73]. In addi-
tion to the routine measures of wearing personal protective
equipment (hats, masks, and gloves), prepping the area with
an alcohol-based solution, and maintaining a sterile ﬁeld,
another option is to tunnel the catheter after placement. A
smallsubcutaneousplacementoftheproximalportionofthe
catheter not only decreases the length of tubing potentially
exposedtocontamination,butitalsohelpsingainingamore
secure catheter placement. Both of these features become
especially advantageous in prolonged epidural catheter use.
8. Complications of EpiduralAnesthesia
Epidural anesthesia and analgesia are generally considered
to be safe with regards to adverse post procedural events, as
their complications, resulting in permanent deﬁcits, are rare.
Besides their indications and obvious beneﬁts, knowledge of
adverse outcomes should also comprise an essential part of
clinical decision making.
Complications of central neuraxial blockade, much
depending on the experience in patient management, as well6 Anesthesiology Research and Practice
Sacrococcygeal ligament
Sacral comua
Figure 1: Placing the probe transverse plane at the coccyx, the
sacral cornua (represented in white arrows heading down) are
viewed laterally as humps. Sacral hiatus is located between an upper
hyperechoic line, representing the sacrococcygeal membrane or
ligament and an inferior hyperechoic line representing the dorsum
of the pelvic surface of the sacrum (bidirectional sided arrow).
Dorsal surface of the
sacrum
Pelvic surface of sacrum
Caudal
catheter
(a)
Caudal
catheter
Dorsal surface of the
sacrum
Local anesthetic
spread
Pelvic surface of sacrum
(b)
Figure 2: (a) Placing the probe longitudinally between the sacral
cornua will capture the dorsal surface of the sacrum, the dorsal
aspect of the pelvic surface of the sacrum, and the sacrococcygeal
ligament. Angiocatheter penetrated the sacrococcygeal ligament
and lies in the epidural space. (b) Local Anesthetic spread through
Caudal Angiocatheter in caudal epidural space.
as materials, equipment, and the presence of risk factors,
have been reported to occur at various frequencies [74, 75].
An epidemiologic study conducted in Sweden over a period
of10yearsrevealedanincreasingtrend(1in10,000neuraxial
anesthetics) of severe complications after central neuraxial
blockade [74]. Relatively recent literature suggests that most
D o r s a ls u r f a c eo fs a c r u m
P e l v i cs u r f a c eo fs a c r u m
Catheter
Figure 3: Caudal epidural catheter passing through Angiocatheter
in the epidural space.
Figure 4: Longitudinal view at the thoracic spine level, viewing
the advancement of the caudal epidural catheter. Curved lines
show spinous processes. Arrows show epidural catheter in between
spinous processes.
of these occur with the perioperative use of epidural block
[74, 76]. The incidence of major complications (permanent
harm including death) of epidural and combined spinal-
epidural anesthesia were at least twice as high as those of
spinalandcaudalblocks,asreportedbyCookandcolleagues.
This study also found that the incidence of epidural catheter-
related serious morbidity and mortality was higher when
blocks were placed in the perioperative setting, as opposed
to catheter placement in obstetric and pediatric populations,
when inserted for chronic pain management, or when placed
by non-anesthetists [77]. While prognosis is infrequently
reported, retrospective reviews report full recovery in 61–
75% of patients, epidural hematoma accounting for two-
thirds of residual neurological deﬁcits [77, 78]. Serious
complications, if not recognized and treated at an early
stage, may thus result in permanent loss of function [74,
79]. With regards to the timing of catheter placement,
there is still substantial controversy: while many anesthesia
providers believe that epidural catheters should be placed
in awake or mildly sedated patients capable of providing
feedback [80], Horlocker’s retrospective review found no
evidence of an increased risk for neural injury in anes-
thetized patients receiving epidural anesthetic [81]. Thoracic
epidural placement, however, should never be attempted
on an anesthetized patient. Having increasingly becomeAnesthesiology Research and Practice 7
Figure 5: Longitudinal view at the lumbar spine. Visualization of
the local anesthetic spread conﬁrmed the position.
the focus of attention, and as a result of both meticulous
adherence to sterile, atraumatic catheter insertion technique
and management, as well as careful risk-beneﬁt assessment,
major complications of epidural anesthesia are now rare,
particularly those not involving infection or bleeding, and
many resolving within 6 months [74]. The estimation of
the incidence of all adverse outcomes, however, is often
inaccurate.
Complications may occur early if related to traumatic
catheter insertion, or later in the operative-postoperative
course if caused by catheter-related spinal space-occupying
lesions such as epidural hematoma or abscess formation,
and are infrequent among the general population. Although
its incidence is lower than when associated with spinal
anesthesia [80], transient neurological injury has been found
to account for the majority of short-term epidural catheter
related complications (1 in 6,700) in a meta-analysis by
Ruppen and colleagues, followed by deep epidural infections
(1 in 145,000), epidural hematoma (1 in 150,000–168,000),
and persistent neurological injury (1 in 257,000) in women
receiving epidural catheter for childbirth [82, 83]. Spinal
epidural hematoma, however, has been recently suggested
to occur in a rate as high as 1 in 3,600 in female patients
undergoing knee arthroplasty [74, 84, 85]. These ﬁndings
were consistent with those previously reported in the ASA
ClosedClaimsProjectdatabaseanalysisbyLeeetal;however,
limitations of that study design and database do not allow
risk quantiﬁcation speciﬁc to regional anesthetic techniques
or populations [86].
Adverse events may result from direct mechanical injury
or adverse physiological responses. Neurological complica-
tions resulting from accidental penetration of the dura are
similar to those that occur with spinal anesthesia. Inad-
vertent dural puncture and postdural puncture headache,
direct neural injury, total spinal anesthesia, and subdural
block have been commonly reported. The incidence of
inadvertent dural puncture ranges between 0.19–0.5% of
epidural catheter placements. Postdural puncture headache
(PDPH), described as a positional, bilateral frontal-occipital,
nonthrobbing pain, may develop in as much as 75% of
patients [87–89]. PDPH is thought to develop as a result
of persistent transdural leakage of cerebrospinal ﬂuid (CSF)
at a rate that is faster than that of CSF production. The
subsequently decreasing CSF volume and pressure causes
traction on the meninges and intracranial vessels, which
refer pain to the frontal-occipital region, often extending to
the neck and shoulders, more pronounced in the upright
position. Available measures of prevention besides conserva-
tive measures are immediate intrathecal catheter placement,
prophylactic epidural blood patch, epidural or intrathecal
administration of saline, and epidural administration of
morphine [90]. Direct neural injury has a reported incidence
of 0.006% [82], and has been associated with paresthesias
during needle placement and pain on injection [80]. Total
spinal anesthesia may occur if the solution used for epidural
anesthesia is inadvertently administered into the intrathecal
space in large volumes. Symptoms are of a rapidly arising
subarachnoid block, potentially resulting in cardiovascular
collapse and apnea requiring prompt resuscitation. Provided
that immediate, skilled resuscitative eﬀorts are made, com-
p l e t er e c o v e r ys h o u l db ee x p e c t e d[ 91]. While clinically not
always distinguishable from epidural blocks, the incidence
of clinically recognized subdural block was found to be
0.024% in a prospective study [92] .As u b d u r a lb l o c km a y
present as high sensory block, often with sparing of motor
and sympathetic ﬁbers, is slow in onset, and the blockade
is disproportionately extensive for the volume of anesthetic
injected. Clinical signs and symptoms may be mistaken
for accidental intrathecal injection, migration of epidural
catheter, or an asymmetrical, patchy or inadequate epidural
block.Subduralplacementisthoughttooccurindependently
of the operator’s expertise. Although there are no established
risk factors, recent lumbar puncture and rotation of the
needle may predispose to subdural injection [93].
Hemorrhagic complications are serious adverse out-
comes that may arise from neuraxial anesthesia. Epidural
hematomaisarare,butpotentiallydevastating,complication
that requires emergency decompression in case of clinical
deterioration. It is rarely attributed to an arterial source,
and can develop spontaneously [94, 95]. While paralysis may
occur even after hematoma evacuation, it is still not precisely
understood why several of the spinal epidural hematomas
associated with concurrent anticoagulant use involving less
bloodthanthevolumeinjectedwhenperformingatherapeu-
tic blood patch [85]. Clinically signiﬁcant bleeding is more
likely with congenital or acquired coagulation abnormalities,
thrombocytopenia, vascular anomalies or anatomical abnor-
malities,advanced ageandfemalegender,repetitive attempts
atcatheterinsertion,andtraumaticblockplacement[74,96–
98]. The risk is reported to increase 15-fold when there
is a concomitant use of anticoagulants, and appropriate
precautions are not taken [85]. Appropriate timing of
anticoagulant administration is important in decreasing the
risk of bleeding [99]. The commonest presenting symptoms
of spinal epidural hematoma are new back pain, radicular
pain, and progressive lower extremity weakness. Symptoms
rarely present immediately after surgery, but may develop
while the catheter is still in place. These symptoms can
occur 15 hours to 3 days after catheter insertion [78, 98].
The diagnostic investigation of choice is MRI. A delay in
diagnostic imaging may lead to devastating outcomes, and
is a common error, as manifesting neurological symptoms
and back pain may be attributed to the use of epidural8 Anesthesiology Research and Practice
infusion and a prolonged eﬀect of local anesthetic, and to
musculoskeletal origin [78, 100]. Cauda equina syndrome
due to hematoma formation, a rare complication with a
reportedincidenceof2.7/100,000 epiduralblocks,wasfound
to result in permanent deﬁcit in more than two-third of the
cases [74]. Classic manifestation is low back pain, altered
proprioception and decreased sensation to pinprick and
temperature in the lumbar and sacral nerve distribution,
voiding and defecation disturbances, and progressive loss of
muscle strength.Outcomesareprimarily functionofinterval
to hematoma evacuation and the severity of the neurological
deﬁcit, and are favorable if decompression is performed
within 8 hours of the development of symptoms [98].
Epidural catheter related infections are rare compli-
cations both in adult and in pediatric patients. A ret-
rospective database analysis by Sethna et al. found an
expected incidence ranging between 3–13/10,000 catheters
in children [101]. Epidural abscess and meningitis has
been reported to occur in 1:1000 and 1:50,000 catheter
placements, respectively [74]. Although epidural catheters
are placed under aseptic conditions, needle or catheter
contamination does occur even during aseptic puncture and
sterile handling of devices [102]. Of patient risk factors, skin
colonization at the puncture site and bacterial migration
along the catheter is proposed to be the most likely route of
i n f e c t i o n ;h o w e v e r ,i m m u n o s u p p r e s s i o n[ 74, 103], diabetes
mellitus [104], chronic renal failure, steroid administration,
cancer, herpes zoster, rheumatoid arthritis [105], systemic
or local sepsis, and prolonged infusion duration are also
identiﬁable risk factors. The rate of skin colonization at
puncture sites is reported to be higher in children than
in adults, with an overall incidence as high as 35% [101].
The incidence of infection increases after three days [106].
The classic presentation signs and symptoms are severe
midline back pain, fever, and leukocytosis, with or without
neurologicalsymptoms (worsening lowerlimbweaknessand
paraplegia, incontinence, irradiating pain, nuchal rigidity,
and headache). Symptoms commonly appear after removal
of the epidural catheter [78]. Neurological deﬁcits have
been found to be persistent in more than 50% of patients
developing epidural abscess [105]. Barrier precautions, skin
disinfection [107], as well as the use of closed epidural
system, and patient-controlled epidural analgesia [101]h a v e
been suggested as ways to decrease the incidence of epidural
catheter-associated infections. Frequent syringe changes, on
the other hand, may be associated with a higher rate of
epidural infections [108]. Frequently implicated infecting
organisms are Methicillin-resistant Staphylococcus aureus
(MRSA), Staphylococcus aureus, and Coagulase-negative
Staphylococcus [101, 109]. Outcomes are favorable when
diagnosedandtreatedpromptly.Adhesivearachnoiditis,pre-
senting in various forms, is a sterile inﬂammatory response
to accidental subarachnoid injection of local anesthetics,
preservatives, detergents, or antiseptics [110–112], and has
also resulted from traumatic puncture or epidural abscess.
Medical literature suggests an extremely low incidence [113,
114].
Complications of epidural anesthesia are rare events
that may result in detrimental sequelae. Strict adherence
to prophylactic measures and treatment without delay is
essential to further lower the incidence of adverse outcomes.
9. EpiduralAnesthesiaand
Thromboprophylaxis
Some controversy exists with regards to reduced coagulation
and neuraxial anesthesia and challenges are emerging as
new agents are introduced into clinical practice. Spinal
epidural hematoma, although still considered to be a rare
complication occurring at a previously reported rate of less
than 1 in 150,000 epidural and less than 1 in 220,000 spinal
anesthetics in patients with normal coagulation status, is
n o ws u g g e s t e dt oo c c u ri nar a t ea sh i g ha s1i n3 , 0 0 0
in some patient populations [84, 85]. Patients receiving
antithrombotic or antiplatelet therapies are more at risk for
this potentially dramatic adverse event, in particular after
invasive procedures [98]. In the United States, the estimated
incidence of spinal epidural hematoma with concurrent
administration of antithrombotic drugs (low molecular
weight heparins) is 1:40,800 for spinal anesthesia, 1:6,600
for single-shot epidural anesthesia, and 1:3,100 for continu-
ous epidural anesthesia [85]. Risk factors for epidural bleed-
ingwereestablishedascoagulationdisorders,antithrombotic
or ﬁbrinolytic therapy, or the use of any agents interfering
with coagulation, female gender, age, diﬃcult vertebral or
spinalcordanatomy,diﬃcultortraumaticcatheterinsertion,
and lack of guidelines [96, 98, 115, 116]. Catheter removal
carries nearly the same risk as insertion [98]. Appropriate
time intervals between the administration of anticoagulants,
neuraxial block placement, and catheter removal are crucial
in the prevention of hematoma formation [117, 118].
The American Society of Regional Anesthesia and Pain
Medicine (ASRA), and more recently, the European Society
of Anaesthesiology (ESA) published their consensus state-
ments on neuraxial anesthesia and the use of antithrombotic
and thrombolytic agents [99, 119]. While providing guide-
lines in clinical decision making, and having the aim of min-
imizinghemorrhagiccomplications,theserecommendations
do not guarantee a speciﬁc outcome, and allow of variations
basedonthejudgmentoftheanesthesiologist.Theguidelines
of the American Society of Regional Anesthesia and Pain
Medicine and the European Society of Anaesthesiology are
based on previously published national recommendations,
hematology, pharmacology, and risk factors for surgical
bleeding, and incorporate updated information since the
time of their publication.
With regards to epidural catheter placement, the ASRA
recommends that patients receiving thrombolytic therapy
be queried and their medical records reviewed for a recent
history of lumbar puncture or neuraxial analgesia. Neuraxial
anesthesia should be avoided, or, if received concurrently
with the ﬁbrinolytic/thrombolytic therapy, close neuro-
logical monitoring should be continued along with the
administration of neuraxial solutions that minimize sensory
and motor block. There is no deﬁnitive recommendation for
epidural catheter removal in patients receiving ﬁbrinolytic
and thrombolytic therapy. Thrombolytics, if scheduled,Anesthesiology Research and Practice 9
should be avoided for 10 days after puncture of noncom-
pressible vessels [99].
Patients receiving unfractionated heparin (UFH) thrice a
day, if recommended by recent thromboprophylaxis guide-
lines, may be at an increased risk of surgical-related bleed-
ing. The ASRA recommends that the patient’s—potentially
simultaneous—anticoagulant and antiplatelet medication be
daily reviewed. There is no contraindication to epidural
blockade in patients receiving subcutaneous UFH prophy-
laxis at daily doses of 2 × 5000U. The risk of bleeding
may be increased in debilitated patients receiving prolonged
therapy, and may be decreased by delaying the heparin
injection until after neuraxial block placement. The safety of
central neural block in patients receiving subcutaneous UFH
in a dosing regimen of more than 10,000U daily has not
been established, and an increased risk of a spinal epidural
hematoma has also not been elucidated. Patients receiving
heparin for greater than 4 days should be assessed for
heparin-induced thrombocytopenia (HIT). In patients with
knowncoagulopathies,combiningneuraxialtechniqueswith
intraoperative heparinization should be avoided however,
this technique is acceptable in patients with no other
coagulation disorders, if
(1) heparin administration is delayed for 1 hour after
puncture,
(2) epidural catheters are removed 2 to 4 hours after the
last heparin dose and the patient’s coagulation status
is assessed. the next heparin dose may be adminis-
tered 1 hour after catheter removal,
(3) patient is closely monitored for early signs of neuro-
logic dysfunction while receiving neuraxial solutions
that minimize sensory and motor block postopera-
tively.
Per the ASRA guidelines, in contrast with the ESA
recommendations that suggest considering postponement of
the procedure, diﬃcult or traumatic block placement should
not necessarily prompt postponing surgery; however, the
potential beneﬁts should be carefully weighed against all
potentially detrimental outcomes in each individual. With
regards to the full anticoagulation of patients undergoing
cardiac surgery, the ASRA ﬁnds insuﬃcient evidence avail-
able to determine an increased risk of neuraxial hematoma.
Close postoperative monitoring of neurologic function, as
well as administration of neuraxial solutions that minimize
sensory and motor block to facilitate detection of signs
and symptoms of cord compression, is however suggested
[99, 119].
Patients on low molecular weight heparin (LMWH)
anticoagulation have not been found to be at an increased
risk of bleeding in high-risk groups, contrasting with
patients receiving UFH-thromboprophylaxis. Also, com-
pared to UFH, LMWH-therapy has been associated with
a signiﬁcant decrease in the risk of HIT, as demonstrated
by Warkentin and colleagues [120]; nonetheless, LMWHs
are contraindicated in such condition due to the high level
of cross-reactivity. To avoid an elevated risk of bleeding
complications, an interval of 10 to 12 hours between
preoperative LMWH administration at prophylactic doses
and needle placement or catheter removal is recommended.
Administration of LMWH the night before surgery does
not thus interfere with epidural block placement on the
day of surgery. In patients on therapeutic doses of LMWH,
catheter placement should be delayed for a minimum of
24 hours after the last dose. Patients undergoing general
surgery and receiving LMWH 2 hours prior to surgery are
not ideal candidates for a neuraxial blockade, and are thus
recommended against neuraxial techniques. Patients receiv-
ing postoperative LMWH thromboprophylaxis may safely
be administered both single-dose and continuous catheter
techniques. With regards to management, timing of the ﬁrst
postoperative dose, dosing schedule, and total daily dose
are authoritative. Concerning the management of patients
receivingLMWH,theASRArecommendsagainsttheroutine
monitoring of anti-Xa level and concurrent administration
of medication aﬀecting hemostasis, regardless of LMWH
dosing regimen [99, 119].
The management of patients receiving perioperative
oral anticoagulants is still controversial. In the United
States, much like in Europe, therapeutic oral anticoagulation
is considered as a contraindication to central neuraxial
blockade. As opposed to Europe, however, perioperative
thromboprophylaxis is still possible in the United States.
According to the recommendation of the American Society
of Regional Anesthesia and Pain Medicine, warfarin therapy
must be stopped ideally 4-5 days before the scheduled
procedure, and the INR checked before neuraxial block
placement. In patients receiving an initial preoperative
dose of warfarin, INR should be measured before needle
puncture if the administration of the ﬁrst dose exceeded 24
hours, or if a second dose of such anticoagulant has been
administered. In patients at risk for an enhanced response
to oral anticoagulants, a reduced dose of drug should be
administered. In patients receiving low-dose warfarin during
epidural analgesia, INR should be monitored daily. Epidural
catheters should be removed when the INR is less than 1.5.
If the INR is greater than 1.5 but less than 3, indwelling
epidural catheters should be done with caution. The ASRA
recommends against concurrent use of agents, such as UFH,
LMWH, or platelet aggregation inhibitors, that inﬂuence
other components of the clotting system, as these, without
aﬀecting the INR, may increase the risk of bleeding. Medical
records should be reviewed for such agents. Neurologic
testing of sensory and motor function should be performed
routinely during epidural analgesia for patients on oral
anticoagulants, and should be continued for at least 24
hours after catheter removal, until the INR returns to the
desired prophylactic range. In patients with INR greater than
3, the American Society of Regional Anesthesia and Pain
Medicine recommends that the warfarin be held or reduced,
without making a deﬁnitive recommendation regarding the
management to facilitate catheter removal in these patients
[99, 119].
Platelet aggregation inhibitors, such as acetylsalicylic
acid, thienopyridines (clopidogrel, ticlopidine, and prasug-
rel), glycoprotein (GP) IIb/IIIa antagonists (eptiﬁbatide,
tiroﬁban, and abciximab), the novel ADP P2Y12 receptor10 Anesthesiology Research and Practice
antagonist ticagrelor, and the selective phosphodiesterase
IIIA inhibitor cilostazol, have diverse eﬀects on platelet
function. No wholly accepted test exists to guide antiplatelet
therapy. It is therefore critical to perform a careful pre-
operative risk assessment to identify factors that might
potentially contribute to bleeding. Although administration
of nonsteroidal anti-inﬂammatory drugs (including aspirin)
does not appear to signiﬁcantly increase the incidence of
hematomaformation,concurrentadministrationofLMWH,
UFH, or oral anticoagulants resulted in a higher rate of
complications in both surgical and medical patients, their
use along with NSAIDs, including aspirin, is therefore not
recommended. Cyclooxygenase-2 inhibitors have minimal
inhibitory eﬀect on platelet aggregation, and should be
considered in patients requiring anti-inﬂammatory therapy
in the presence of anticoagulation. The actual incidence of
spinal epidural hematoma related to thienopyridines and
GP IIb/IIIa inhibitors is not known. Management should
be based on labeling precautions and the experience of
professionals involved in the clinical care of the patient.
However, as it has been suggested by recent guidelines,
ticlopidine and clopidogrel therapy should be discontinued
14 and 7days prior to neuraxial block, respectively. If
needle puncture is indicated between 5 and 7 days of
discontinuation of clopidogrel, normalization of platelet
function should be documented. GP IIb/IIIa antagonists
exert a dose-dependent eﬀect on platelet aggregation. After
the last administered dose, the time to normal aggregation
is 4 to 8 hours for eptiﬁbatide and tiroﬁban, and 24 to 48
hours for abciximab. Neuraxial blockade should be avoided
until normal platelet function is achieved. Should a patient,
despite the contraindication, be administered GP IIb/IIIa
inhibitors within 4 weeks of surgery, careful neurological
monitoring should be performed [99, 119].
Both the ASRA and the ESA guidelines recommend
against the mandatory discontinuation of herbal agents
(most commonly: garlic, Echinacea, Gingko biloba, ginseng,
aloe vera, and ephedra of dwarf palm), neither should
neuraxial techniques be avoided, as there is insuﬃcient
evidence that these, by themselves, signiﬁcantly increase the
risk for spinal hematoma formation. There is insuﬃcient
evidence to conclude that thrombin inhibitors, such as
lepirudin, desirudin, bivalirudin, or argatroban, are safer
to use in patients receiving spinal or epidural anesthesia;
performance of these techniques in the presence of these
agents is thus not recommended. Until suﬃcient evidence
is available, neuraxial techniques in patients receiving fon-
daparinux should only be performed if single needle pass,
atraumatic block placement, and avoidance of indwelling
catheters are feasible, or a diﬀerent method of prophylaxis
should be considered [99, 119].
10. Summary
Epidural and caudal anesthesia is a versatile neuraxial
anesthetic technique with an expanding area of indication. It
can be used in the perioperative setting as the sole anesthetic,
or in combination with general or spinal anesthesia. Its
potential to decrease postoperative complication rate by its
beneﬁcialphysiologicaleﬀectshasbeen clearlydemonstrated
in several studies. The absolute contraindications to its use
have traditionally been well deﬁned. Despite its rare, but
potentially devastating complications, neuraxial anesthesia
is considered to be safe. Performing such procedures in the
presence of anticoagulants is however controversial. With
patients presenting with medical conditions that predispose
to clinically signiﬁcant bleeding and an increased number
of patients taking various anticoagulants, there is greater
concern for an increased incidence of epidural hematomas.
The key to maximizing the advantages while minimizing
the disadvantages of epidural and caudal anesthesia is to
become familiar with the anatomical, physiological, phar-
macological, and technical aspects of block placement. The
review and advances discussed here allow both adult and
pediatric populations a form of care that is often considered
indispensable.
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